Molecular Mechanisms Associated with Neurodegeneration in Alzheimer's disease
Main Article Content
Abstract
Alzheimer's disease (AD) is a progressive and irreversible pathology in which there is a continuous neurodegeneration process, clinically characterized by decreased cognition, memory and behavior alterations. Currently, the mechanisms behind AD progression are more clear, redefining it as a multifactorial disease on which aging, genetics,metabolism and environment play an important role on the onset. The complex molecular mechanisms interplay and generate a state of inflammation.Thus, creating neurodegeneration.
Objectives: This review focuses on recopilating and describing the molecular mechanism behind neurodegeneration in AD. Furthermore, the relation between risk factors and the mechanism will be encompassed.
Methods: A bibliographical review was carried out. Databases such as Pubmed, MDPI,sciencedirect, Termidia publishing house, scielo and the National institute of aging were used. Articles in English and Spanish between 2004 and 2023 were included. The keywords used were:Alzheimer's disease, neurodegeneration, beta-amyloid, tau protein, neuroinflammation, cognitive disorder, tangles, biomarkers.
Results and discussion: Millions of people are exposed to multiple risk factors for AD. In every one of them, there are molecular mechanisms involved, which will eventually lead to AD´s main pathological changes, Beta amyloid deposition and tau pathology, causing neurodegeneration.
Conclusions: Alzheimer's disease is an international public health problem that is affecting the lives of millions of people.To address this, we have to fully understand the molecular base of its development, in order to approach new treatments.
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. Andrade, 2023 https://www.mdpi.com/1422-0067/24/4/3754
II. GPC alzheimer,2017
III. Fernandez,2013
IV. Yeo,2011
V. Rekatsina,2020 https://pubmed.ncbi.nlm.nih.gov/31782132/ 6-
VI. Kumar,2022 https://www.ncbi.nlm.nih.gov/books/NBK499922/
VII. Nebel,2018
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400070/
VIII. Soria,2019
https://www.sciencedirect.com/science/article/abs/pii/B9780128047668000133?via%3 Dihub
IX. Eratne,2018 https://journals.sagepub.com/doi/10.1177/1039856218762308?url_ver=Z39.88-2003&rf r_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed
X. Breijyeh,2020 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764106/
XI. Armstrong,2019
https://www.termedia.pl/Risk-factors-for-Alzheimer-s-disease,20,36928,1,1.html
XII. Mega,2020 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670800/
XIII. Pope, 2021
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917676/
XIV. Mold,2020
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7683092/
XV. Rabinovici,2019 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6548536/
XVI. Verghese,2013
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3651443/
XVII. Rodriguez,2020
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378785/
XVIII. Gomez,2022
https://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S0016-381320220004002 44
XIX. O'connor, 2016
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5066138/
XX. Elahi,2021
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8355229/
XXI. Johnson,2010 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979339/
XXII. McKee,2015
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4526170/
XXIII. Briggs,2016 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922703/#R24
XXIV. Rukmangadachar,2023 https://www.ncbi.nlm.nih.gov/books/NBK459119/
XXV. Crous-Bou,2017 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5596480/
XXVI. Siddappaji,2021 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8222772/#:~:text=Molecular%20mecha
nism%20in%20the%20brain%20at%20AD%20state,Protein%20beta%20(sAPP%20% CE%B2)
XXVII. Logan,2019 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6880148/
XXVIII. Vazquez,2011
https://dialnet.unirioja.es/servlet/tesis?codigo=180811#:~:text=Tau%20es%20una%20f
osfoprote%C3%ADna%20implicada,lugar%20a%20la%20degeneraci%C3%B3n%20n eurofibrilar.
XXIX. Hansen,2018 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5800817/
XXX. Hanslik,2020
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530640/
XXXI. Weller,2018
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6073093/
XXXII. Scheltens,2021 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354300/
XXXIII. Huang,2023 https://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-023-00976-6